The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective evaluation of the factors predicting the prognosis of advanced hepatocellular carcinoma (HCC) patients treated with sorafenib.
 
Takuya Adachi
Research Funding - Bayer Yakuhin (Inst)
 
Kazuhiro Nouso
Research Funding - Bayer Yakuhin (Inst)
 
Koji Miyahara
No Relationships to Disclose
 
Chihiro Dohi
Research Funding - Bayer Yakuhin (Inst)
 
Nozomu Wada
Research Funding - Bayer Yakuhin (Inst)
 
Yasuto Takeuchi
Research Funding - Bayer Yakuhin (Inst)
 
Kenji Kuwaki
Research Funding - Bayer Yakuhin (Inst)
 
Hideki Onishi
Research Funding - Bayer Yakuhin (Inst)
 
Fusao Ikeda
Research Funding - Bayer Yakuhin (Inst)
 
Shinichiro Nakamura
Research Funding - Bayer Yakuhin (Inst)
 
Hidenori Shiraha
Research Funding - Bayer Yakuhin (Inst)
 
Koichi Takaguchi
No Relationships to Disclose
 
Shuji Uematsu
No Relationships to Disclose
 
Shouta Iwadou
No Relationships to Disclose
 
Yoshitaka Takuma
No Relationships to Disclose
 
Hiroaki Hagihara
No Relationships to Disclose
 
Hiroyuki Takabatake
No Relationships to Disclose
 
Akinobu Takaki
Research Funding - Bayer Yakuhin (Inst)
 
Hiroyuki Okada
Research Funding - Bayer Yakuhin (Inst)